Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from Deciphera Pharmaceuticals (DCPH) is now available.
Following the merger on June 11, 2024, Deciphera has made significant changes including the termination of various equity and stock plans, the resignation of several board members, and the appointment of new ones. Additionally, the company has amended its certificate of incorporation and by-laws, notified Nasdaq to suspend trading, and intends to cease its reporting obligations. Furthermore, Deciphera has canceled its upcoming Annual Meeting of Stockholders originally scheduled for June 20, 2024.
See more data about DCPH stock on TipRanks’ Stock Analysis page.
